Skip to search formSkip to main contentSkip to account menu

cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet [Stribild]

National Institutes of Health

Related topics

Related topics

2 relations
Oral TabletStribild

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
In vitro–in vivo correlation of the drug–drug interaction potential of antiretroviral HIV treatment regimens on CYP1A1 substrate riociguat
ABSTRACT Objectives: Riociguat is a soluble guanylate cyclase stimulator licensed for the treatment of pulmonary arterial… 
2015
2015
P41 Stribild™ (Emtricitabine/Tenofovir/Elvitegravir/Cobicistat) and darunavir: a novel regimen for the pi experienced, ritonavir intolerant patient
Case report We present the case of a 42 yr old female, diagnosed with HIV in 1992, presenting on a failing PI and integrase… 
2015
2015
P17.36 Effectiveness, safety and tolarebility profile of stribild® (elvitegravir/cobicistat/emitricitabine/tenofovir disoproxil fumarate) in hiv-1-infected patients in the clinical setting
Introduction The efficacy of Stribild ® , an integrase strand transfer inhibitor (INSTI) -based STR, has been evaluated in… 
2015
2015
Effectiveness, Safety, and Tolerability Profile of Stribild® in HIV-1-infected Patients in the Clinical Setting
2014
2014
Stribild®: a guide to its use in HIV-1 infection in adults in the EU
The oral fixed-dose elvitegravir/cobicistat/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) single tablet (Stribild®) is… 
2013
2013
Stribild, a Single Tablet Regimen for the Treatment of HIV Disease
IntroductionIn August 2012, the US Food and Drug Administration (FDA) approved a new single tablet once-a-day therapy for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)